Project Details
Status | Finished |
---|---|
Effective start/end date | 1/11/2011 → 31/12/2013 |
Collaborative partners
- King's College London (lead)
- BerryPharma
- TSB Technology Strategy Board
- GSK GlaxoSmithKline Research & Development Ltd
Funding
- TSB Technology Strategy Board: £168,764.00
- GSK GlaxoSmithKline Consumer Healthcare: £11,375.00
- GSK GlaxoSmithKline Consumer Healthcare: £15,346.00